PE20080038A1 - Derivados de tiazolidinadiona como inhibidores de la pi3 quinasa - Google Patents
Derivados de tiazolidinadiona como inhibidores de la pi3 quinasaInfo
- Publication number
- PE20080038A1 PE20080038A1 PE2007000423A PE2007000423A PE20080038A1 PE 20080038 A1 PE20080038 A1 PE 20080038A1 PE 2007000423 A PE2007000423 A PE 2007000423A PE 2007000423 A PE2007000423 A PE 2007000423A PE 20080038 A1 PE20080038 A1 PE 20080038A1
- Authority
- PE
- Peru
- Prior art keywords
- diona
- methylidene
- thiazolidine
- quinolinyl
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
SE REFIERE A COMPUESTOS DERIVADOS DE TIAZOLIDINADIONA DE FORMULA (I) DONDE R1 ES HETEROARILO DE 5 A 12 MIEMBROS OPCIONALMENTE SUSTITUIDO CON H, HALOGENO, NH2, TRIFLUOROMETILO, ENTRE OTROS; R2 ES H, ALQUILO(C1-C6), ARILO(C5-C10) O ARILALQUILO OPCIONALMENTE SUSTITUIDOS CON H, HALOGENO, CN, OH, ENTRE OTROS; R3 Y R4 SON CADA UNO H, HALOGENO, ALQUILO(C1-C6), CN, NITRO, ENTRE OTROS; n ES DE 0 A 2. SON COMPUESTOS PREFERIDOS: (5Z)-5-{[4-(4-PIRIDINIL)-6-QUINOLINIL]METILIDENO}-1,3-TIAZOLIDINA-2,4-DIONA, (5Z)-3-METIL-5-{[4-(4-PIRIDINIL)-6-QUINOLINIL]METILIDENO}-1,3-TIAZOLIDINA-2,4-DIONA, (5Z)-5-{[4-(3-PIRIDINIL)-6-QUINOLINIL]METILIDENO}-1,3-TIAZOLIDINA-2,4-DIONA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE FOSFATOINOSITIDO 3 QUINASAS (PI3K) SIENDO UTILES EN EL TRATAMIENTO DE ASMA, ESCLEROSIS MULTIPLE, PSORIASIS, ARTRITIS REUMATOIDE, LUPUS ERITEMATOSO SISTEMICO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79113406P | 2006-04-11 | 2006-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20080038A1 true PE20080038A1 (es) | 2008-02-22 |
Family
ID=38723938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007000423A PE20080038A1 (es) | 2006-04-11 | 2007-04-09 | Derivados de tiazolidinadiona como inhibidores de la pi3 quinasa |
Country Status (19)
Country | Link |
---|---|
US (1) | US20090306074A1 (es) |
EP (1) | EP2004189A2 (es) |
JP (1) | JP2009533467A (es) |
KR (1) | KR20080108611A (es) |
CN (1) | CN101466377A (es) |
AR (1) | AR060391A1 (es) |
AU (1) | AU2007253956A1 (es) |
BR (1) | BRPI0710004A2 (es) |
CA (1) | CA2649224A1 (es) |
CL (1) | CL2007000995A1 (es) |
CR (1) | CR10354A (es) |
EA (1) | EA200870426A1 (es) |
IL (1) | IL194575A0 (es) |
MA (1) | MA30395B1 (es) |
MX (1) | MX2008013174A (es) |
NO (1) | NO20084457L (es) |
PE (1) | PE20080038A1 (es) |
TW (1) | TW200815429A (es) |
WO (1) | WO2007136940A2 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080255115A1 (en) * | 2007-04-11 | 2008-10-16 | Michael Gerard Darcy | Thiazolidinedione derivatives as pi3 kinase inhibitors |
PE20090717A1 (es) * | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
GB0801416D0 (en) * | 2008-01-25 | 2008-03-05 | Piramed Ltd | Pharmaceutical compounds |
EP2482819A4 (en) | 2009-09-28 | 2013-02-20 | Glaxosmithkline Llc | COMBINATION |
RU2458688C1 (ru) * | 2011-06-23 | 2012-08-20 | Государственное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ коррекции нарушений структурно-функциональных свойств эритроцитов и иммунного статуса у больных с острым панкреатитом |
WO2013146435A1 (ja) * | 2012-03-26 | 2013-10-03 | 日本ケミファ株式会社 | 骨・軟部に発生する巨細胞性腫瘍または軟骨肉腫の予防または治療剤 |
JP6023630B2 (ja) * | 2013-04-03 | 2016-11-09 | 株式会社ヤクルト本社 | チアゾロン誘導体 |
JP6378918B2 (ja) * | 2013-04-03 | 2018-08-22 | 株式会社ヤクルト本社 | チアゾリジン誘導体又はその塩を有効成分とするPim阻害剤 |
KR20220000993A (ko) | 2013-09-25 | 2022-01-04 | 닛뽕 케미파 가부시키가이샤 | 골·연부에 발생하는 거세포성 종양, 연골육종 또는 골육종의 예방, 치료 또는 전이 예방을 위한 약제, 동맥색전술용 국소 주입제 및 인공골 |
WO2019157516A1 (en) | 2018-02-12 | 2019-08-15 | resTORbio, Inc. | Combination therapies |
WO2019241789A1 (en) | 2018-06-15 | 2019-12-19 | Navitor Pharmaceuticals, Inc. | Rapamycin analogs and uses thereof |
AU2020397938A1 (en) | 2019-12-05 | 2022-06-23 | Janssen Pharmaceutica Nv | Rapamycin analogs and uses thereof |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0783496B9 (en) * | 1994-08-10 | 2003-09-03 | Takeda Chemical Industries, Ltd. | Thiazolidinedione derivatives, their production and use |
US5925656A (en) * | 1995-04-10 | 1999-07-20 | Dr. Reddy's Research Foundation | Compounds having antidiabetic, hypolipidemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
US6452014B1 (en) * | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
AU2002252227A1 (en) * | 2001-03-07 | 2002-09-24 | Maxia Pharmaceuticals, Inc. | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases |
CN1513175A (zh) * | 2001-03-28 | 2004-07-14 | 拜尔公司 | 在信息层中包含作为吸光化合物的部花青染料的光学数据载体 |
US20050019825A9 (en) * | 2002-03-15 | 2005-01-27 | Qing Dong | Common ligand mimics: pseudothiohydantoins |
US7348348B2 (en) * | 2002-04-30 | 2008-03-25 | Merck & Co. Inc. | Aryl-link-aryl substituted thiazolidine-dione and oxazolidine-dione as sodium channel blockers |
US20040092561A1 (en) * | 2002-11-07 | 2004-05-13 | Thomas Ruckle | Azolidinone-vinyl fused -benzene derivatives |
AU2003255528B2 (en) * | 2002-07-10 | 2009-07-16 | Merck Serono Sa | Azolidinone-vinyl fused-benzene derivatives |
US20050222225A1 (en) * | 2002-07-10 | 2005-10-06 | Applied Research Systems Ars Holding Nv | Use of compounds for increasing spermatozoa motility |
EP1597255A1 (en) * | 2002-11-13 | 2005-11-23 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
WO2005007123A2 (en) * | 2003-07-18 | 2005-01-27 | Pintex Pharmaceuticals, Inc. | Pin1-modulating compounds and methods of use thereof |
EP1648452B1 (en) * | 2003-07-28 | 2009-07-22 | Merck Serono SA | 2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors |
EP1654380A4 (en) * | 2003-08-14 | 2009-09-09 | Insight Biopharmaceuticals Ltd | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING HEPARANASE ACTIVATION AND USES THEREOF |
KR100856363B1 (ko) * | 2004-07-01 | 2008-09-04 | 에프. 호프만-라 로슈 아게 | Cdk1 항증식 활성을 갖는 퀴놀린 티아졸리논 |
US7253285B2 (en) * | 2004-09-17 | 2007-08-07 | Hoffmann-La Roche Inc. | Thiazolinone 4-monosubstituted quinolines |
US20080255115A1 (en) * | 2007-04-11 | 2008-10-16 | Michael Gerard Darcy | Thiazolidinedione derivatives as pi3 kinase inhibitors |
-
2007
- 2007-04-09 AR ARP070101487A patent/AR060391A1/es unknown
- 2007-04-09 CL CL200700995A patent/CL2007000995A1/es unknown
- 2007-04-09 TW TW096112219A patent/TW200815429A/zh unknown
- 2007-04-09 PE PE2007000423A patent/PE20080038A1/es not_active Application Discontinuation
- 2007-04-11 CA CA002649224A patent/CA2649224A1/en not_active Abandoned
- 2007-04-11 US US12/296,708 patent/US20090306074A1/en not_active Abandoned
- 2007-04-11 KR KR1020087027465A patent/KR20080108611A/ko not_active Application Discontinuation
- 2007-04-11 MX MX2008013174A patent/MX2008013174A/es not_active Application Discontinuation
- 2007-04-11 EA EA200870426A patent/EA200870426A1/ru unknown
- 2007-04-11 CN CNA2007800218014A patent/CN101466377A/zh active Pending
- 2007-04-11 AU AU2007253956A patent/AU2007253956A1/en not_active Abandoned
- 2007-04-11 WO PCT/US2007/066359 patent/WO2007136940A2/en active Application Filing
- 2007-04-11 JP JP2009505582A patent/JP2009533467A/ja not_active Withdrawn
- 2007-04-11 EP EP07811839A patent/EP2004189A2/en not_active Withdrawn
- 2007-04-11 BR BRPI0710004-3A patent/BRPI0710004A2/pt not_active Application Discontinuation
-
2008
- 2008-10-06 IL IL194575A patent/IL194575A0/en unknown
- 2008-10-07 CR CR10354A patent/CR10354A/es not_active Application Discontinuation
- 2008-10-22 NO NO20084457A patent/NO20084457L/no not_active Application Discontinuation
- 2008-11-03 MA MA31349A patent/MA30395B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EA200870426A1 (ru) | 2009-04-28 |
MA30395B1 (fr) | 2009-05-04 |
US20090306074A1 (en) | 2009-12-10 |
AR060391A1 (es) | 2008-06-11 |
MX2008013174A (es) | 2008-10-21 |
IL194575A0 (en) | 2009-08-03 |
AU2007253956A1 (en) | 2007-11-29 |
TW200815429A (en) | 2008-04-01 |
BRPI0710004A2 (pt) | 2011-08-02 |
NO20084457L (no) | 2009-01-07 |
JP2009533467A (ja) | 2009-09-17 |
CR10354A (es) | 2008-10-29 |
EP2004189A2 (en) | 2008-12-24 |
WO2007136940A3 (en) | 2008-12-04 |
KR20080108611A (ko) | 2008-12-15 |
CN101466377A (zh) | 2009-06-24 |
WO2007136940A2 (en) | 2007-11-29 |
CA2649224A1 (en) | 2007-11-29 |
CL2007000995A1 (es) | 2008-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20080038A1 (es) | Derivados de tiazolidinadiona como inhibidores de la pi3 quinasa | |
PE20120321A1 (es) | Indazoles sustituidos con oxazol como inhibidores de pi3-quinasa | |
PE20080925A1 (es) | DERIVADOS DE PIRROLO[2,3-b]PIRIDINA COMO INHIBIDORES DE QUINASA, EN PARTICULAR INHIBIDORES IKK2 (O IKK BETA) | |
TW200637550A (en) | Thiazole-4-carboxamide derivatives as mGluR5 antagonists | |
MX2011011485A (es) | Sulfonamidas nematocidas. | |
PE20090288A1 (es) | Derivados de quinoxalina como inhibidores de la pi3 quinasa | |
MX343596B (es) | Sulfonamidas nematocidas. | |
PE20090887A1 (es) | DERIVADOS DE 1H-PIRAZOL-[3,4-d]-PIRIMIDINA, 9H-PURINA Y 7H-PIRROL-[2,3-d]-PIRIMIDINA COMO INHIBIDORES DE CINASA P70 S6 | |
PE20091466A1 (es) | Derivados de 4,5-dihidro-oxazol-2-il-amina | |
PE20090617A1 (es) | Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa | |
RS54260B1 (en) | AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT | |
PE20140975A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
MX2008011123A (es) | Benzotiazoles que tienen actividad de receptor h3 de histamina. | |
PE20081362A1 (es) | DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K | |
PE20090773A1 (es) | Derivados de morfolina pirimidina | |
SG154434A1 (en) | Quinazolinone derivatives as parp inhibitors | |
IL192580A0 (en) | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors | |
PE20110063A1 (es) | DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
PE20091561A1 (es) | Compuestos inhibidores de raf y metodos para su uso | |
PE20081845A1 (es) | Nuevos derivados de aminopirimidina como inhibidores de plk1 | |
MX2007007428A (es) | Compuestos heterociclicos, antagonistas de ccr2b. | |
MX2009002239A (es) | Derivados de 5-(2-furil)-1,3-tiazol util como inhibidores de fosfatidilinositol 3-cinasa. | |
MX2010000658A (es) | Derivados de pirimidina 934. | |
ATE553106T1 (de) | Heteroarylpyrrolopyridinone als kinaseinhibitoren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |